648 related articles for article (PubMed ID: 22399305)
1. Interpretation and recommended testing for antiphospholipid antibodies.
Galli M
Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
[TBL] [Abstract][Full Text] [Related]
2. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid inhibitors. State of the art.
Galli M
Hamostaseologie; 2011 Nov; 31(4):243-6, 248, 250. PubMed ID: 21881700
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory examinations in antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
Persijn L; Decavele AS; Schouwers S; Devreese K
Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
[TBL] [Abstract][Full Text] [Related]
8. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
9. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice.
Roubey RA
Lupus; 2010 Apr; 19(4):440-5. PubMed ID: 20353985
[TBL] [Abstract][Full Text] [Related]
10. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid syndrome: critical analysis of the diagnostic path.
Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
[TBL] [Abstract][Full Text] [Related]
13. Antibody profiles for the diagnosis of antiphospholipid syndrome.
Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
15. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
16. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
19. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies.
Favaloro EJ; Wheatland L; Jovanovich S; Roberts-Thomson P; Wong RC
Semin Thromb Hemost; 2012 Jun; 38(4):390-403. PubMed ID: 22570184
[TBL] [Abstract][Full Text] [Related]
20. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
